Cerebrovascular Diseases Flashcards
Enumerate and define the boundaries of the ACA segments
A1 horizontal: ICA to ACOM
A2 vertical: ACOM to callosomarginal artery
A3 callosal: distal to callosomarginal artery
Enumerate and define the boundaries of the ICA segments
C1: cervical segment C2: petrous (horizontal) segment C3: lacerum segment C4: cavernous segment C5: clinoid segment C6: supraclinoi) segment C7: communicating segment
Enumerate and define the boundaries of the MCA segments
M1 horizontal or sphenoidal segment: origin to bi/trifurcation (the limen insulae)
M2 insular segment: bi/trifurcation to circular sulcus of insula where it makes hairpin bend to continue as M3
M3 opercular segment: opercular branches (those within the Sylvian fissure)
M4 cortical segment: branches emerging from the Sylvian fissure onto the convex surface
Enumerate and define the boundaries of the PCA segments
P1: basilar artery to Pcom
P2: Pcom to the posterior aspect of the midbrain
P3: posterior aspect of the midbrain to calcarine fissure
P4: distal to the anterior limit of the calcarine fissure
Enumerate and define the boundaries of the vertebral arteries segments
V1 preforaminal: origin to C6 transverse foramen
V2 foraminal: C6 to the C2
V3 atlantic or extradura): C2 to the dura
V4 intradural: dura to basilar artery
Branches of the A1 segment of the ACA
A1 (horizontal): ICA to ACOM
1 medial lenticulostriate artery
2 recurrent artery of Heubner3 Acom
Branches of the A2 segment of the ACA
A2 vertical: ACOM to callosomarginal artery
1 orbitofrontal artery
2 frontopolar artery
Branches of the A3 segment of the ACA
A3 callosal: distal to callosomarginal artery
1 pericallosal artery
2 callosomarginal artery (runs in the cingulate sulcus)
Segments of the ICA that has no branches
C1: cervical segment
C3: lacerum segment
C5: clinoid segment
Branches of the C2 segment of the ICA
C2: petrous (horizontal) segment
1 caroticotympanic artery
2 vidian artery
Branches of the C4 segment of the ICA
C4: cavernous segment
1 meningohypophyseal trunk
2 inferolateral trunk
Branches of the C6 segment of the ICA
C6: supraclinoid segment
1 ophthalmic artery
2 superior hypophyseal artery
Branches of the C7 segment of the ICA
1 Pcom
2 anterior choroidal artery
3 ACA
4 MCA
What is the ABCD2 scoring?
1 point age>=60 1 point BP: S >=140 or D >=90 Clinical feature: 2 points unilateral 1 point speech 1 point Diabetes Duration 2 points >=60 mins 1 point 10-59 mins
ABCD2 Scores 2day Risk of stroke
0-3: 1%
4-5: 4.1%
6-7: 8.1%
CHA2DS2-VASc
Congestive Heart Failure Hypertension Age>75* Diabetes Stroke/TIA/TE* Vascular Disease Age>65 Sex
*2 points
score>=2 is HIGH RISK
HASBLED
Hypertension >160 Abnormal liver renal function Stroke Bleeding tendency Labile INR Elderly>65 Drugs (alcohol)
> =3 high risk
Speltzer Martin Scoring
size of nidus 6cm = 3 eloquence of adjacent brain non-eloquent = 0 eloquent = 1 venous drainage superficial only = 0 deep = 1
Risk of aneurysmal rupture for ruptured?
3-4% first 24 hours then 1-2%/day first month, 3% per year after 3 months
Sensitivity of CT scan in detecting SAH in 12 hours
98-100%
Angiogram sensitivity in detecting aneurysm
x
Stroke RCT: ATC
Antiplatelet Trialist Collaboration
ASA vs Placebo
Odds reduction of composite outcome by 33%
Stroke RCT: CAPRIE
Clopidogrel vs Aspirin in at Risk for Ischemic Events
Clopidogrel 8.7% reduction compared to Aspirin
Stroke RCT: MATCH
Management of Atherothrombotic Risk with Clopidogrel
Clopidogrel+Aspirin vs Clopidogrel
Negative study
Higher hemorrhage in dual antiplatelet
Stroke RCT: CHARISMA
Clopidogrel for High Risk and Ischemic Stabilization Management and Avoidance
Clopidogrel+Aspirin vs Aspirin
Same
Increased hemorrhage in dual antiplatelet
Stroke RCT: SPS3
Secondary Prevention of Small Subcortical Strokes
Clopidogrel + Aspirin vs Aspirin
Same
Increased hemorrhage in dual antiplatelet
Stroke RCT: CSPS1
Cilostazol in Stroke Prevention Study
Cilostazol vs Placebo
41.7% risk reduction of recurrent ischemic strome
Stroke RCT: TOSS
Trial of Cilostazol Symptomatic Intracranial Stenosis
Cilostazol+Aspirin vs Aspirin
Progression of intracranial stenosis by MRA was less in dual antiplatelet
Stroke RCT: TOSS 2
Trial of Cilostazol in Symptomatic Intracranial Stenosis
Cilostazol+Aspirin vs Clopidogrel+Aspirin
No difference in rate of ICAS progression
But more hemorrhage in Clopidogrel
Stroke RCT: CATS
Canadian American Stroke Study
Ticlopidone vs Placebo
30% Composite outcome reduction
Stroke RCT: TASS
Ticlopidone vs Aspirin Stroke Study
Ticlopidone vs Aspirin
Reduced stroke or death by 12%
Neutropenia in Ticlopidone
Stroke RCT: ESPS1
European Stroke Prevention Study 1
Dipyrimadole+Aspirin vs placebo
33% reduction
Stroke RCT: ESPS2
European Stroke Prevention Study 2
4 arms
Dipyridamole+Aspirin vs
Dipyridamole vs
Aspirin vs placebo
Stroke reduction compared to placebo: 37.8% 18% 16% No increased bleeding
Stroke RCT: ESPRIT
European/Australasian Stroke Prevention in Reversible Ischemia
Dipyridamole+Aspirin vs Aspirin
Dual antiplatelet 20% reduced composite outcome
No increased bleeding
Stroke RCT: PROFESS
Prevention Regimen for Effectively Avoiding Second Stroke
Dipyridamole+Aspirin vs Clopidogrel
Similar rates of recurrent ischemic stroke
More hemorrhage in dual antiplatelet
Stroke RCT: TACIP
Trifusal Aspirin in Cerbral Infarction Prevention
Trifusal vs Aspirin
Similar efficacy
Less hemorrhage in trifusal
Stroke RCT: TAPIRSS
Trifusal vs Aspirin in the Prevention of Infarction: A Randomized Stroke Study
Trifusal vs Aspirin
No significant difference in combined endpoint
Less hemorrhage in Trifusal
Stroke RCT: WARSS
Warfarin Aspirin Recurrent Stroke Study
Warfarin vs Asprin
No significant difference
Stroke RCT: WASID
Warfarin Aspirin in Symptomatic Intracranial Disease
Warfarin vs Aspirin
No significant difference
Stroke RCT: CSPS2
Cilostazol Stroke Prevention Study 2
Cilostazol vs Aspirin
Non inferiority
Antidote for Dabigatran
Idarucizumab
FUNC scoring
Volume Location Age GCS Cognitive Impairment
30day mortality risk ICH scoring
GCS Volume Intraventricular Hemorrhafe Infratentorial Age
FUNC scoring
Volume Location Age GCS Cognitive Impairment
30day mortality risk ICH scoring
GCS Volume Intraventricular Hemorrhafe Infratentorial Age
FUNC scoring
Volume Location Age GCS Cognitive Impairment
30day mortality risk ICH scoring
GCS Volume Intraventricular Hemorrhafe Infratentorial Age
Sensitivity of CT scan in detecting SAH in 24 hours
93%
Sensitivity of CT scan in detecting SAH in 6 days
57-85%
If CT Scan is unavailable, the most sensitive MRI studies for detecting SAH are?
T2 Gradient Echo
FLAIR
If cerebral angiogram is negative in SAH, repeat when?
7-14 days
In SAH, surgery may be delayed if there is:
Ischemia or severe angiographic vasospasm
For poor grade SAH (HHIV-V), early surgery may be done if:
Hematoma
Hydrocephalus
ICH lifetime risk in a patient with AVM
=105-age
Morbidity risk of AVM for each bleed
30-50%
Mortality risk of ruptured AVM for each bleed
10%
Bleeding risk in a patient with AVM if unruptured
2-4% per year
Overall mortality rate from AVM hemorrhage for adults
1%
Overall mortality rate from AVM hemorrhage for children
2%
ICH lifetime risk in a patient with AVM
=105-age
Morbidity risk of AVM for each bleed
30-50%
Mortality risk of ruptured AVM for each bleed
10%
Bleeding risk in a patient with AVM if unruptured
2-4% per year
Overall mortality rate from AVM hemorrhage for children
2%
Overall mortality rate from AVM hemorrhage for adults
1%
In SAH, surgery may be delayed if there is:
Ischemia or severe angiographic vasospasm
For poor grade SAH (HHIV-V), early surgery may be done if:
Hematoma
Hydrocephalus
Consistent risk factors that increase risk of hemorrhage in AVM
1 deep venous drainage
2 single draining vein
3 venous stenosis
4 high MAP in the feeding artery
Inconsistent risk factors that increase risk of hemorrhage in AVM
1 intranid aneurysms
2 deep location
3 small nidus
4 venous stasis
Potential risk factors that increase risk of hemorrhage in AVM
1 hypertension 2 increasing age 3 smoking 4 pregnancy 5 vertebrobasilar supply 6 perforating supply
AVM score for Radiosurgery
=0.1Volume + 0.02Age + 0.5Location
1 point if: BG, thalamus, brainstem
Treatment of choice for cavernous malformation
Microsurgery
Types CCF
type A: a direct connection between the intracavernous ICA and CS
type B: dural shunt between intracavernous branches of the ICA and CS
type C: dural shunts between meningeal branches of the ECA and CS
type D: B + C
CHADS2
Congestive Heart Failure Hypertension Age>75 Diabetes Stroke/TIA/TE
Fisher Grading
1: no subarachnoid (SAH) or intraventricular haemorrhage (IVH) detected
2: diffuse thin (1 mm in thickness +/- intracranial haemorrhage (ICH) or IVH
4: no or thin SAH + ICH or IVH
WFNS Classification
GCS 15 GCS 13-14 without deficit GCS 13-14 with focal neurological deficit GCS 7-12 GCS
Absolute Contraindications to rTPA
x
In cerebral infarction, there is a early ___1_____ diffusivity followed by later ___2_____ diffusivity on MRI
1 Reduced
2 Elevated
Brainstem syndromes
X
In cerebral infarction, there is a early ___1_____ edema followed by later ___2_____ edema on MRI
1 cytotoxic
2 vasogenic
Mode of action of Citcoline
x
High risk cardioembolic source 9
1 AF 2 recent MI 3 Atrial myxoma 4 Rhematic MS 5 Prosthetic valves 6 Infective Endocarditis 7 Marantic Endocarditis 8 dilated CM 9 Left thrombus
low risk cardioembolic source 6
1 PFO 2 Mitral annular calcification 3 Mitral valve prolapse 4 Mitral valve strands 5 Aortic stenosis 6 Atrial septal aneurysm
Exclusion criteria for rtpa treatment with time window of 4.5 hours (4)
1 >80 years old
2 anticoagulant use
3 NIHSS>25
4 history of both ischemic stroke and diabetes